Sigma merger won’t benefit consumers: EBOS

Pharmaceutical wholesaler warns that Chemist Warehouse’s proposed reverse takeover of Sigma will have a negative impact on consumer choice  Allowing Sigma Healthcare’s proposed merger with Chemist Warehouse go ahead will make an already dominant player in the market get stronger, a competitor warns.  John Cullity, the chief executive of EBOS, which operates pharmaceutical wholesaler, Symbion